Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

GU Cancers 2020 | Nivolumab for nccRCC

Laurence Albiges, MD, PhD, Gustave Roussy Institute, Villejuif, France discusses the methods and results of the AcSé study (NCT03012581), which investigated the use of nivolumab in rare cancers such as metastatic non-clear cell renal cell carcinoma (nccRCC). This interview took place at the 2020 Genitourinary Cancers Symposium, held in San Francisco, CA.

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.